News
-
Two open positions: Application / Service Engineer and Customer Support Scientist
26.10.2020
We are hiring. Apply by 8th of November 2020.
-
Influenza or COVID-19? Reliable diagnosis in 75 minutes with new multiplex assay
23.9.2020
-
GenomEra SARS-CoV-2 Assay Kit is now CE IVD approved and development for four-in-one test (FluA, FluB, RSV, SARS-CoV-2) is on-going
17.7.2020
GenomEra SARS-CoV-2 Assay Kit is now CE IVD approved and available. Please contact your local distributor or us for more information.
In addition, we are developing a four-in-one test for detecting influenza A, influenza B, RSV and SARS-CoV-2. Targeted release is before winter Flu season 2020-2021. -
Investment round is now open
5.6.2020
We warmly welcome all new investors!
#Crowdfunding #CapitalAtRiskhttps://abacusdiagnostica.com/invest
-
Special approval granted for SARS-CoV-2 test
4.5.2020
Finnish regulatory authority Fimea has granted special approval for Abacus to supply the GenomEra RUO SARS-CoV-2 test to Finnish markets.
Press release in Finnish -
First SARS-CoV-2 Test Kits Shipped
30.3.2020
Our team has been working hard on past weeks and today we shipped first GenomEra SARS-CoV-2 test kits for our customers.
Press-release in Finnish: https://bit.ly/2UvaMC2
-
Abacus is now on Twitter
26.3.2020
Abacus is now on Twitter! We will tweet the latest news and more relaxed stories frequently. Some big news coming next week – stay tuned! https://twitter.com/AbacusCDX #AbacusCDX
-
Recent publication: GenomEra C. difficile test demonstrates increased reliability for standalone molecular diagnostics
11.3.2020
While covid19 is spreading, there are still other worries to deal with. Standalone PCR testing for C. difficile diagnostics is often criticized for overdiagnosis of CDI. In a recent publication (doi:10.1128/JCM.01872-19) GenomEra routine samples were retested with two different toxin immunoassays and discrepant results were confirmed with culture or GeneXpert. Results shows perfect 100% PPV and excellent 99.7% NPV for GenomEra. Study reports insufficient sensitivities of 81.6% and 71.7% for two different toxin immunoassay from ArcDia and TechLab, respectively.
-
Announcement of a new distributor
28.1.2020
We are proud to announce our new distributor:
-NexGen Molecular Supplies, South Africa.
Please visit https://www.abacusdiagnostica.com/distributors/ to view the complete list. #pcr #abacusdiagnostica #molecular #diagnostics
-
New results from MRSA/SA AC and S.pneumoniae tests compared to culture.
16.1.2020
Poster P-124 from #Ricai 2019 poster session demostrates a study by Manon Prat et.al how our tests GenomEra MRSA/SA AC and GenomEra S.pneumoniae perform when suspected of superinfection with #influenza and #RSV. Using an optimized protocol and clinical samples, our tests correlate 100% with culture results. #moleclardiagnostics #pcr #poitiers #abacusdiagnostica #GenomEra
